R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis Investing in biologics excellence Eloise McLennan Antonio Magnelli, biologics, Chiesi Group, Sustainability 0 Comment In little over three decades, advances in biotechnology have noticeably disrupted the development landscape of small molecule drugs. Share X Investing in biologics excellence https://pharmaphorum.com/r-d/investing-in-biologics-excellence/
Antonio Magnelli, biologics, Chiesi Group, Sustainability
0 Comment
